Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract

Product Details
Customization: Available
Application: Ophthalmology
Usage Mode: For external use
Gold Member Since 2014

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (11)
  • Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract
  • Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract
  • Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract
Find Similar Products

Basic Info.

Model NO.
15ml
Suitable for
Children, Adult
State
Liquid
Type
Biological Products
Pharmaceutical Technology
Natural Product Extraction
Origin
China
HS Code
3004909099
Production Capacity
500000

Product Description

Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract

Cataract is common among the aged. It is most important cause of blindness in ophthalmology. For a long time , there has no satisfactory therapeutic measure for cataract with the exception of surgery. In addition to various surgical operations, the ophthalmologists have paid close attention to drug therapy. 
Clinical experiments have shown that " Baineiting " Pireenoxine sodium Eye Drops is effective to prevent the advancement of cataract. In early stage of senile cataract , proper administration of Pirenoxine sodium Eye Drops is effective to stop the degenerate in vision for senile cataract. It is safe in administration.

COMPOSITION:
One tablet contains Pirenoxine sodium 0.8mg. Pirenoxine sodium is the active component for cataract.
Solvent 15ml each squeezing bottle. The solvent is an isotonic , buffered solution , which is used specially for dissolving the pirenoxine sodium tablet , it has the function to stabilizing the active component in the tablet.

ACTION:
Bichemical researches have recently been done in elucidating the etiology of cataract, it has been proposed that cataract develops in case the soluble protein in lens gradually convent into insoluble preteins owing to the action of quinoid substances. Quinoid substances turn up as a result of the abnormal metabolism of tryptophan an important amino acid in physiological function. The action of quinold substances upon the soluble protein in lens is found to be inhibited competitively by Pirenoxine sodium the active component of this preparation. Therefore administration of Pirenoxine sodium Eye Drops is effective to prevent the advancement of cataract.

DIRECTIONS FOR USE:
The preparation supplied in special form of two separated parts , a tablet containing the active component and a bottle of solvent for the tablet. Dissolve one tablet in the attached 15ml solvent before application.
Western Medicine GMP Pirenoxine Sodium Eye Drops Ophthalmology Cataract

DOSAGE:
Instill 1-2 drops of prepared solution, 3-4 times a day.

PRECAUTIONS:
1. Once the tablet is dissolved in the solvent , the prepared solution must be used up without cessation within 20 days.

2. Don't hold the bottle's mouth touching your eye when you drop the solution. Avod to pollute the solution.

3. Precaution: Preserve in well- closed , light-resistant containers. The prepared solution may be carried by patients for use it they are out.

SUPPLIED:
One tablet plus 15ml solvent in a bottle.

STORAGE:
Preserved in well closed, light-resistant containers (Don't store the product above 25ºC)

ADVERSE REACTIONS:
Mild stinging in the eye.


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier